Stay updated on Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedMajor update: page version bumped to v3.2.0 and a government funding operating-status notice added; previous v3.0.2 revision removed.SummaryDifference2%

- Check26 days agoChange DetectedUpdate reflects a version upgrade from v3.0.2 to v3.1.0; no other content changes are indicated.SummaryDifference0.1%

- Check33 days agoChange Detected- Removed sections on MedlinePlus drug safety topics, counterfeit drugs, pharmaceutical preparations, and substandard drugs, narrowing the page’s coverage of drug safety and pharmacology.SummaryDifference0.3%

- Check40 days agoChange DetectedUpdated the page to Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of various locations and facility names, while also removing several previously listed locations. Notably, the facility names and locations related to drug safety and counterfeit drugs have been emphasized.SummaryDifference8%

Stay in the know with updates to Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.